Case studies Archive

Jul 01, 2021
Hong Kong sees record IPO proceeds in first half of 2021
Hong Kong IPOs raised record funds in the first half of 2021 amid a global boom in listings, according to new research from KPMG. During the first six months of the year, the city saw 46 deals, raising a total of HK$213.2 bn ($27.4 bn), finds the study. That represents a 130 percent increase on the total funds raised in the first half of 2020....
Read more
Jun 30, 2021
The Long-Term Stock Exchange gains first listing commitments
The Long-Term Stock Exchange (LTSE) has gained its first listing commitments from Asana and Twilio. Both companies are expected to list on LTSE on August 26, 2021 via dual public listings of their common stock. The LTSE launched in September 2020 after gaining approval from the SEC in May 2019. The exchange’s principles-based listing standards prioritize long-term actions and promote transparency by requiring listed companies to detail and publish policies that of...
Read more
Jun 24, 2021
Novo Nordisk and Cyfrowy Polsat claim three awards each at IR Magazine Awards – Europe 2021
Novo Nordisk and Cyfrowy Polsat were the big winners at the IR Magazine Awards – Europe 2021, taking home three prizes each at the virtual event. The Danish pharmaceutical company won best overall IR (large cap), best IR officer (large cap) for Daniel Bohsen and best IR in the healthcare sector. Polish media and telecommunications group Cyfrowy Polsat, a newcomer to the awards, claimed best overall IR (mid-cap), best IR officer (small to mid-cap) for Grzego...
Read more
Jun 22, 2021
Advisory Intelligence: Technology sector needs to demonstrate agility to navigate macro concerns
Sponsored content Executives and IR teams in the technology, media and telecoms (TMT) sector should emphasize their company’s agility in navigating increases in interest rates and bond yields, concerns for tech regulation driven by Democrats and the reopening of the pre-pandemic economy. Last year was a banner year for the TMT sector as the pandemic drove the adoption and consumption of more technology-led products and services than ever before. A...
Read more
Jun 17, 2021
How Square managed guidance and cryptovolatility
On March 17, 2020, San Francisco and the surrounding Bay Area counties went into lockdown – the first in the US. For most of the 7 mn residents of the Bay Area, the lockdown raised questions about how to protect themselves from the spread of Covid-19 and how to work remotely. But for the IR team at Square, the financial services and digital payments company, there was the small matter of an investor day that had been planned to take place on March 18, 2020. ...
Read more
Jun 15, 2021
How Unity used a modified auction to go public
It’s not too long ago that the IPO was the only mainstream route to market for private companies in the US, although, in recent years, direct listings and special purpose acquisition companies have taken a sizable share of that pie. For a small number of companies, however, there’s a fourth option: a modified auction.  This was the method chosen by Google in 2004, but it didn’t catch on – at least, not until September 2020, when Unity Software revived it. I...
Read more
Jun 14, 2021
Record number of CFOs believe US equity market is overvalued
As the S&P 500 continues to mark new highs, finance chiefs believe valuations are looking increasingly stretched, according to new research. A record 86 percent of finance chiefs polled by Deloitte for its Q2 CFO Signals report say they believe US stocks are overvalued, a rise from 83 percent last quarter. The respondents, totaling 138 CFOs base...
Read more
Jun 08, 2021
Advisory Intelligence: ‘Deals and data’ are heartbeat of biotech
Sponsored content For companies in the biotech sector, 2021 is off to a fast start as capital-raising among new issuers crossed $6.1 bn as of June 1. The US market has welcomed 45 new biotech listings in the first five months of the year, a staggering increase of 200 percent on the same period in 2020. Following months of relative outperformance last year, however, the biotech sector may face some uncertainty in the coming months, says Jeff Larocque...
Read more
logo-black logo-black